Collection and processing of marrow and blood hematopoietic stem cells

Hematopoietic Stem Cell Transplantation in Clinical Practice

Volumn , Issue , 2009, Pages 249-256

  Cottler Fox, Michele ^a   Montgomery, Matthew ^a   Theus, John ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952470819     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-10147-2.50028-X     Document Type: Chapter

References (90)

1. Thomas ED, Storb R Technique for human marrow grafting. Blood 1970, 36:507-511.
2. Klingemann HG Collection, processing and infusion of marrow. A guide to bone marrow transplantation 1988, Springer-Verlag, New York. H. Deeg, H. Klingemann, G. Phillips (Eds.).
3. Deeg HJ Bone marrow and hematopoietic stem cell transplantation: sorting the chaff from the grain. Bone marrow and stem cell processing: a manual of current techniques 1992, Davis, Philadelphia. E. Areman, H. Deeg, R. Sacher (Eds.).
4. Ferrebee JW, Atkins L, Lochte HL, et al. The collection, storage and preparation of viable cadaver marrow for intravenous use. Blood 1959, 14:140-147.
5. Mugashimi H, Terasaki P, Sueyoshi A Bone marrow from cadaver donors for transplantation. Blood 1985, 65:392-396.
6. Blazar BR, Lasky LC, Perentesis JP, et al. Successful donor cell engraftment in a recipient of bone marrow from a cadaveric donor. Blood 1986, 6:1655-1660.
7. Touraine JL In utero transplantation of fetal liver stem cells in humans. Blood Cells 1991, 17:379-387.
8. Zimmerman TM, Williams SF, Bender JG, et al. Clinical use of selected and expanded peripheral blood CD34+ cells: a preliminary report of feasibility and safety. J Haematother 1995, 4:527-529.
9. Devine SM, Hoffman R Role of mesenchymal stem cells in hematopoietic stem cell transplantation. Curr Opin Hematol 2000, 7:358-363.
10. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-146.
11. Burnett A, Tansey P, Hills C, et al. Haematological reconstitution following high dose and supralethal chemoradiotherapy using stored, non-cryopreserved autologous bone marrow. Br J Haematol 1983, 54:309-316.
12. Gluckman E, Broxmeyer HE, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from an HLA identical sibling. N Engl J Med 1989, 321:1174-1178.
13. Buckner CD, Clift RA, Sanders JE, et al. Marrow harvesting from normal donors. Blood 1984, 64:630-634.
14. Bortin MM, Buckner CD Major complications of marrow harvesting for transplantation. Exp Haematol 1983, 11:916-921.
15. Petersen FB, Buckner CD, Bolonesi B, et al. Marrow harvesting from normal donors. Exp Haematol 1990, 18:676.
16. Heldal D, Brinch L, Tjonnfjord G, et al. Donation of stem cells from blood or bone marrow: results of a randomized study on safety and complaints. Bone Marrow Transplant 2002, 29:479-486.
17. Wilson RE Techniques of human bone marrow procurement by aspiration from living donors. N Engl J Med 1959, 261:781-785.
18. Batinic D, Marusic M, Pavletic Z, et al. Relationship between differing volumes of bone marrow aspirates and their cellular composition. Bone Marrow Transplant 1990, 6:103-107.
19. Cottler-Fox M Bone marrow collection techniques. Bone marrow and stem cell processing: a manual of current techniques 1992, Davis, Philadelphia. E. Areman, H. Deeg, R. Sacher (Eds.).
20. Brandwein JM, Callum J, Rubinger M, et al. An evaluation of outpatient bone marrow harvesting. J Clin Oncol 1989, 7:648-650.
21. Dicke KA, Hood DL, Hanks S, et al. A marrow harvest procedure under local anesthesia. Exp Haematol 1995, 23:1229-1232.
22. Haurani FL, Repplinger E, Tocantis LM Attempts at transplantation of human bone marrow in patients with acute leukemia and other marrow depletion disorders. Am J Med 1960, 28:794-806.
23. Sharp TG, Sachs DH, Matthews JG, et al. Harvest of human bone marrow directly from bone. J Immunol Methods 1984, 69:187-195.
24. Saunders EF, Kapelushnik J, Solh H, et al. Graft vs host disease is reduced in allogeneic bone marrow transplantation using marrow obtained surgically. Blood 1990, 76(Suppl 1):563.
25. Barber WH, Diethelm AG, Laskow DA, et al. Use of cryopreserved donor bone marrow in cadaver kidney allograft recipients. Transplantation 1989, 47:66-71.
26. Rivadeneyra-Espinoza L, Perez-Romano B, Gonzalez-Flores A, et al. Instrument- and protocol-dependent variation in the enumeration of CD34+ cells by flow cytometry. Transfusion 2006, 46:530-536.
27. Suh C, Kim S, Kim SH, et al. Initiation of peripheral blood progenitor cell harvest based on peripheral blood hematopoietic progenitor cell counts enumerated by the Sysmex SE9000. Transfusion 2004, 44:1762-1768.
28. Dao MA, Arevelo J, Nolta JA Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution. Blood 2003, 101:112-118.
29. Hess DA, Wirthlin L, Craft TP, et al. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 2006, 107:2162-2169.
30. Bender JG, To LB, Williams S, Schwartzberg LS Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992, 1:329-341.
31. Weaver CH, Hazelton B, Birch R, et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995, 86:3961-3969.
32. Cottler-Fox M, Lapidot T Mobilizing the older patient with myeloma. Blood Rev 2006, 20:43-50.
33. Koenigsmann M, Jentsch-Ullrich K, Mohren M, et al. The role of diagnosis in patients failing peripheral blood progenitor cell mobilization. Transfusion 2004, 44:777-784.
34. Tricot G, Jagannath S, Vesole D, et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 1995, 85:588-596.
35. Morris CL, Siegel E, Barlogie B, et al. Mobilization of CD34+ cells in elderly patients (>/=70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen. Br J Haematol 2003, 120:413-423.
36. Pastore D, Specchia G, Mestice A, et al. Good and Poor CD34+ cell mobilization in acute leukemia: analysis of factors affecting the yield of progenitor cells. Bone Marrow Transplant 2004, 33:1083-1087.
37. Bensinger W, Appelbaum F, Rowley S, et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995, 13:2547-2555.
38. Fu P, Bagai RK, Meyerson H, et al. Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization. Bone Marrow Transplant 2006, 38:189-196.
39. Olavarria E, Kanfer EJ Selection and use of chemotherapy with hematopoietic growth factors for mobilization of peripheral blood progenitor cells. Curr Opin Hematol 2000, 7:191-196.
40. Ballestrero A, Ferrando F, Garuti A, et al. Comparative effects of three cytokine regimens after high-dose cyclophosphamide: G-CSF, GM-CSF, and sequential interleukin-3 and GM-CSF. J Clin Oncol 1999, 17:1296-1303.
41. Copelan EA Hematopoietic stem-cell transplantation. N Engl J Med 2006, 354:1813-1826.
42. Weaver CH, Schulman KA, Buckner CD Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim. Bone Marrow Transplant 2001, 2(suppl):S23-S29.
43. Anderlini P, Przepiorka D, Seong D, et al. Clinical toxicity and laboratory effects of G-CSF mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Transfusion 1996, 36:590-595.
44. Peters WP, Rosner G, Ross M, et al. Comparative effects of GM-CSF and G-CSF on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 1993, 81:1709-1719.
45. Watts MJ, Addison I, Ings SJ, et al. Optimal timing for collection of PBPC after glycoslyated G-CSF administration. Bone Marrow Transplant 1998, 21:365-368.
46. Stroncek DF, Matthews CL, Follmann D, Leitman SF Kinetics of G-CSF-induced granulocyte mobilization in healthy subjects: effects of route of administration and addition of dexamethasone. Transfusion 2002, 42:597-602.
47. Testa U, Fossati C, Samoggia P, et al. Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progenitors. Blood 1996, 88:3391-3406.
48. Olivieri A, Offidani M, Cantori I, et al. Addition of erythropoietin to granulocyte colony-stimulating factor after priming chemotherapy enhances hemopoietic progenitor mobilization. Bone Marrow Transplant 1995, 16:765-770.
49. Perillo A, Ferrandina G, Pierelli L, et al. Cytokines alone for PBPC collection in patients with advanced gynaecological malignancies: G-CSF vs. G-CSF plus EPO. Bone Marrow Transplant 2004, 34:743-744.
50. Sautois B, Baudoux E, Salmon JP, et al. Administration of erythropoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation. Haematologica 2001, 86:1209-1218.
51. Lapidot T, Petit I Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Haematol 2002, 30:973-981.
52. Dawson MA, Schwarer AP, Muirhead JL, et al. Successful mobilization of peripheral blood stem cells using recombinant human stem cell factor in heavily pretreated patients who have failed a previous attempt with a granulocyte colony-stimulating factor-based regimen. Bone Marrow Transplant 2005, 36:389-396.
53. Da Silva MG, Pimentel P, Carvalhais A, et al. Ancestim (recombinant human stem cell factor, SCF) in association with filgrastim does not enhance chemotherapy and/or growth factor-induced peripheral blood progenitor cell (PBPC) mobilization in patients with a prior insufficient PBPC collection. Bone Marrow Transplant 2004, 34:683-691.
54. Costa JJ, Demetri GD, Harrist TJ, et al. Recombinant human stem cell factor (Kit Ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vitro. J Exp Med 1996, 183:2681-2686.
55. Fricker SP, Anastassov V, Cox J, et al. Characterization of the molecular pharmacology of AMD3100: A specific antagonist of the G-protein coupled chemokine receptor, CXCR4. Biochem Pharmacol 2006, 72:588-596.
56. Flomenberg N, Devine SM, DiPersio JF, et al. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood 2005, 106:1867-1874.
57. Liles WC, Rodger E, Broxmeyer HE, et al. Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist. Transfusion 2005, 45:295-300.
58. ?4. Blood 2004, 103:110-119.
59. Fukuda S, Bian H, King A, Pelus L The chemokine GROb mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment. Blood 2007, 110:860-869.
60. Hosing C, Qazilbash MH, Kebriaei P, et al. Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilization in patients with multiple myeloma. Br J Haematol 2006, 133:533-537.
61. Broxmeyer HE, Orschell CM, Clapp DW, et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 2005, 201:1307-1318.
62. Boeve S, Strupeck J, Creech S, Stiff PJ Analysis of remobilization success in patients undergoing autologous stem cell transplants who fail an initial mobilization: risk factors, cytokine use and cost. Bone Marrow Transplant 2004, 33:991-1003.
63. Goterris R, Hernandez-Boluda JC, Teruel A, et al. Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers. Bone Marrow Transplant 2005, 36:847-853.
64. Lefrere F, Levy V, Makke J, et al. Successful peripheral blood stem cell harvesting with granulocyte colony-stimulating factor alone after previous mobilization failure. Haematologica 2004, 89:1532-1534.
65. Winter JN, Lazarus HM, Rademaker A, et al. Phase I/II study of combined granulocyte colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells. J Clin Oncol 1996, 14:277-286.
66. Gazitt Y Comparison between granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the mobilization of peripheral blood stem cells. Curr Opin Hematol 2002, 9:190-198.
67. Kroger N, Renges H, Sonnenberg S, et al. Stem cell mobilization with 16 μg/kg vs 10 μg/kg of G-CSF for allogeneic transplantation in healthy donors. Bone Marrow Transplant 2002, 29:727-730.
68. Stiff PJ Management strategies for the hard-to-mobilize patient. Bone Marrow Transplant 1999, 23(suppl. 2):S29-S33.
69. Lemoli RM, DeVivo A, Damiani D, et al. Autologous transplantation of G-CSF-primed bone marrow is effective in supporting myeloablative chemotherapy in patients with hematologic malignancies and poor peripheral blood stem cell mobilization. Blood 2003, 102:1595-1600.
70. Beyer J, Schwella N, Zingsem J, et al. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison. J Clin Oncol 1995, 13:1328-1335.
71. Schmitz N, Linch DC, Dreger P, et al. Randomized trial of filgrastim-mobilized peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 1996, 347:353-357.
72. Lazarus HM, Haynesworth SE, Gerson SL, Caplan AI Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections. J Hematother 1997, 6:447-455.
73. Lazarus HM, Haynesworth SE, Gerson SL, et al. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 1995, 16:557-564.
74. Devine SM, Hoffman R Role of mesenchymal stem cells in hematopoietic stem cell transplantation. Curr Opin Hematol 2000, 7:358-363.
75. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-146.
76. Damiani D, Fanin R, Silvestri F, et al. Randomized trial of autologous filgrastim-primed bone marrow transplantation vs. filgrastim-mobilized peripheral blood stem cell transplantation in lymphoma patients. Blood 1997, 90:36-42.
77. Elfenbein GJ, Sackstein R Primed marrow for autologous and allogeneic transplantation: A review comparing primed marrow to mobilized blood and steady-state marrow. Exp Haematol 2004, 32:327-339.
78. Elfenbein GJ, Sackstein R, Oblon DJ Do G-CSF mobilized, peripheral blood-derived stem cells from healthy, HLA-identical donors really engraft more rapidly than do G-CSF primed, bone marrow-derived stem cells?. No! Blood Cells Mol Dis 2004, 32:106-111.
79. Weisdorf D, Miller J, Verfaillie C, et al. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF. Biol Blood Marrow Transplant 1997, 3:217-223.
80. Spitzer TR Bone marrow component processing. Bone marrow and stem cell processing: a manual of current techniques 1992, Davis, Philadelphia. E. Areman, H. Deeg, R. Sacher (Eds.).
81. Stiff PJ Simplified bone marrow cryopreservation using dimethyl sulfoxide and hydroxyethyl starch as cryoprotectants. Bone marrow processing and purging: a practical guide 1991, CRC Press, Boca Raton. A.P. Gee (Ed.).
82. Aird WC, Labopin M, Gorin N, Antin JH Long-term cryopreservation of human bone marrow. Blood 1990, 76(suppl 1):525.
83. Shepherd RM, Capoccia BJ, Devine SM, et al. Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. Blood 2006, 108:3662-3667.
84. Gorin NC Cryopreservation and storage of stem cells. Bone marrow and stem cell processing: a manual of current techniques 1992, Davis, Philadelphia. E. Areman, H. Deeg, R. Sacher (Eds.).
85. Davis J, Rowley S, Santos GW Toxicity of autologous bone marrow graft infusion. Prog Clin Biol Res 1990, 330:531-540.
86. Rowley SD, Davis J, Dick J, et al. Bacterial contamination of bone marrow grafts intended for autologous and allogeneic bone marrow transplantation. Transfusion 1988, 28:109-112.
87. American Code of Federal Regulations. §1271 subpart D. 2006.
88. Aguila HL Regulation of hematopoietic niches by sympathetic innervation. BioEssays 2006, 28:687-691.
89. Katayama Y, Battista M, Wei-Ming K, et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 2006, 124:407-421.
90. Taichman RS, Emerson SG The role of osteoblasts in the hematopoietic microenvironment. Stem Cells 1998, 16:7-15.